Cytosorbents Corp — Director's Dealing 2014

Jun 21, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cytosorbents Corp (CTSO)
CIK: 0001175151
Period of Report: 2014-06-18

Reporting Person: Kraus Al (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-06-18	Common Stock	M	50000	$0.035	Acquired	1443631	Direct
2014-06-18	Common Stock	S	50000	$0.2414	Disposed	1393631	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-18	Stock Option	$0.035	M	50000	Disposed	2018-06-25	Common Stock (50000)	Direct

Footnotes

F1: The price in column 4 is a weighted average price. The prices actually received by the reporting person in this transaction range from $0.241 to $0.242.

F2: The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range reported.